Nutriflex Peri (Valine, Arginine Glutamate, Alanine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine)

The amino acids in Nutriflex Peri serve as direct substrates for protein synthesis and nitrogen balance. By entering the bloodstream, they bypass the gastrointestinal tract, supporting gluconeogenesis, tissue repair, and energy production during periods of catabolic stress or when oral intake is not possible.

The dose of Nutriflex Peri is individualized by the prescribing clinician. It is calculated based on the patient’s weight, nitrogen requirements, renal and hepatic function, and overall metabolic status. The prescriber determines the infusion volume, rate, and duration for each patient.

Safety data for Nutriflex Peri in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Nutriflex Peri, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Nutriflex Peri is comparable to other commercial amino acid formulations such as Aminoven or TrophAmine. All provide balanced essential amino acids for parenteral nutrition, but differences may exist in amino‑acid ratios, osmolarity, and excipients. Clinicians select a product based on patient tolerance, compatibility with other IV fluids, and institutional protocols.

Nutriflex Peri must be stored refrigerated at 2‑8 °C. Keep the container in its original packaging, protect it from light, and avoid freezing or shaking the solution. Before use, inspect for particulate matter or discoloration and discard if any abnormalities are observed.

Nutriflex Peri is administered intravenously as a sterile solution for injection. It is typically diluted in compatible IV fluids and infused over a prescribed period using an infusion pump or controlled drip. Administration guidelines, including rate and monitoring parameters, are set by the treating physician.

Serious risks include anaphylactic reactions, metabolic acidosis, and renal dysfunction, especially in patients with pre‑existing kidney disease. Prompt recognition of signs such as difficulty breathing, sudden drop in blood pressure, or severe electrolyte disturbances is essential, and immediate medical intervention should be initiated.

Nutriflex Peri should be avoided in patients with known hypersensitivity to any of its amino acid components, severe hepatic failure, uncontrolled metabolic disorders, or those receiving incompatible intravenous solutions that may precipitate. Clinicians must evaluate each patient’s medical history before initiating therapy.